Huperzine A

Category
alkaloid
Routes
Oral (PO)
Half-Life (t½)
PO: 12h
Formula
C15H18N2O
Molecular Weight
242.32 g/mol
PubChem CID
854026
Aliases
HupA, Selagine

Pharmacological Mechanism

Reversible acetylcholinesterase inhibitor (Ki ~25 nM) — raises synaptic ACh. Higher CNS selectivity and longer duration than donepezil. Also NMDA receptor antagonist at higher concentrations (neuroprotective rationale). Used in China for Alzheimer's; Western supplement use for cognitive endpoints.

Half-Life & Elimination Curve (PO: 12h)

100%50%25%12.5%0%0h0×t½12h1×t½24h2×t½36h3×t½48h4×t½60h5×t½0×t½ (0h): 100% remaining (~0.608 µg/L)1×t½ (12h): 50% remaining (~0.304 µg/L)2×t½ (24h): 25% remaining (~0.152 µg/L)3×t½ (36h): 12.5% remaining (~0.076 µg/L)4×t½ (48h): 6.3% remaining (~0.038 µg/L)5×t½ (60h): 3.1% remaining (~0.019 µg/L)
Plasma (PO)t½ Decay (12h)
  • 0×t½0h100% (0.608 µg/L)
  • 1×t½12h50% (0.304 µg/L)
  • 2×t½24h25% (0.152 µg/L)
  • 3×t½36h12.5% (0.076 µg/L)
  • 4×t½48h6.3% (0.038 µg/L)
  • 5×t½60h3.1% (0.019 µg/L)
Elimination t½12h (PO)
Rate Constant (ke)0.0578 h⁻¹
Time to Peak (Tmax)2.26h
Est. Peak (Cmax)0.608 µg/L
Clearance (CL)8.09 L/h
97% Washout (5×t½)60h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References